Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
N Prakash, P Stumbles & CS Mansfield. (2019) Concentrations of interleukin-6, -8, -10 and tumour necrosis factor-α in the faeces of dogs with acute diarrhoea. New Zealand Veterinary Journal 67:3, pages 138-142.
Read now
Read now
Christer G. B. Peterson, Maria Lampinen, Tony Hansson, Maria Lidén, Roger Hällgren & Marie Carlson. (2016) Evaluation of biomarkers for ulcerative colitis comparing two sampling methods: fecal markers reflect colorectal inflammation both macroscopically and on a cellular level. Scandinavian Journal of Clinical and Laboratory Investigation 76:5, pages 393-401.
Read now
Read now
C. G. B. Peterson, P. Sangfelt, M. Wagner, T. Hansson, H. Lettesjö & M. Carlson. (2007) Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis. Scandinavian Journal of Clinical and Laboratory Investigation 67:8, pages 810-820.
Read now
Read now
Steven T Leach & Andrew S Day. (2006) S100 proteins in the pathogenesis and diagnosis of inflammatory bowel disease. Expert Review of Clinical Immunology 2:3, pages 471-480.
Read now
Read now
Helene Lettesjö, Tony Hansson, Christer Peterson, Kjell-Arne Ung, Gisela Ringström, Hasse Abrahamsson & Magnus Simrén. (2006) Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis. Scandinavian Journal of Gastroenterology 41:1, pages 54-59.
Read now
Read now
Articles from other publishers (48)
HS Rohith, Muthukumar Serva Peddha & Prakash Motiram Halami. (2023) Probiotic Bacillus licheniformis MCC2514 and Bifidobacterium breve NCIM 5671 Regulates GATA3 and Foxp3 Expression in the Elevated Disease Condition. Probiotics and Antimicrobial Proteins.
Crossref
Crossref
Esther Sánchez-Tirado, Lourdes Agüí, Araceli González-Cortés, Susana Campuzano, Paloma Yáñez-Sedeño & José Manuel Pingarrón. (2023) Electrochemical (Bio)Sensing Devices for Human-Microbiome-Related Biomarkers. Sensors 23:2, pages 837.
Crossref
Crossref
Jumana Samara, Shirin Moossavi, Belal Alshaikh, Van A. Ortega, Veronika Kuchařová Pettersen, Tahsin Ferdous, Suzie L. Hoops, Amuchou Soraisham, Joseph Vayalumkal, Deonne Dersch-Mills, Jeffrey S. Gerber, Sagori Mukhopadhyay, Karen Puopolo, Thomas A. Tompkins, Dan Knights, Jens Walter, Harish Amin & Marie-Claire Arrieta. (2022) Supplementation with a probiotic mixture accelerates gut microbiome maturation and reduces intestinal inflammation in extremely preterm infants. Cell Host & Microbe 30:5, pages 696-711.e5.
Crossref
Crossref
Graham J. Britton, Alice Chen-Liaw, Francesca Cossarini, Alexandra E. Livanos, Matthew P. Spindler, Tamar Plitt, Joseph Eggers, Ilaria Mogno, Ana S. Gonzalez-Reiche, Sophia Siu, Michael Tankelevich, Lauren Tal Grinspan, Rebekah E. Dixon, Divya Jha, Adriana van de Guchte, Zenab Khan, Gustavo Martinez-Delgado, Fatima Amanat, Daisy A. Hoagland, Benjamin R. tenOever, Marla C. Dubinsky, Miriam Merad, Harm van Bakel, Florian Krammer, Gerold Bongers, Saurabh Mehandru & Jeremiah J. Faith. (2021) Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19. Scientific Reports 11:1.
Crossref
Crossref
Sundus Bhatti, Imad Jaafar, Hamza Hassan, Hadi Atassi, Abigail Stocker, Michael Hughes, Christina Pinkston, Gerald Dryden & Thomas Abell. (2020) Effects of Gastric Neuromodulation on Crohn’s Disease in Patients With Coexisting Symptoms of Gastroparesis. Neuromodulation: Technology at the Neural Interface 23:8, pages 1196-1200.
Crossref
Crossref
Yuyang Liu, Thomas Burton, Benjamin Saul Rayner, Patrick T. San Gabriel, Han Shi, Mary El Kazzi, XiaoSuo Wang, Joanne M. Dennis, Gulfam Ahmad, Angie L. Schroder, Antony Gao, Paul Kenneth Witting & Belal Chami. (2020) The role of sodium thiocyanate supplementation during dextran sodium sulphate-stimulated experimental colitis. Archives of Biochemistry and Biophysics 692, pages 108490.
Crossref
Crossref
Patrick San Gabriel, Yuyang Liu, Angie Schroder, Hans Zoellner & Belal Chami. (2020) The Role of Thiocyanate in Modulating Myeloperoxidase Activity during Disease. International Journal of Molecular Sciences 21:17, pages 6450.
Crossref
Crossref
Pietro Celi, Viviane Verlhac, Estefania Pérez Calvo, Jerome Schmeisser & Anna-Maria Kluenter. (2019) Biomarkers of gastrointestinal functionality in animal nutrition and health. Animal Feed Science and Technology 250, pages 9-31.
Crossref
Crossref
Süleyman Günay, Ferda Taşova, Huriye Erbak Yılmaz, Zehra Betül Paköz & Cem Çekiç. (2019) Serum Resolvin E1 Levels and Its Relationship with Disease Activity in Ulcerative Colitis. Gastroenterology Research and Practice 2019, pages 1-5.
Crossref
Crossref
Chuanshang Cheng, Hongkui Wei, Huichao Yu, Chuanhui Xu, Siwen Jiang & Jian Peng. (2018) Metabolic Syndrome During Perinatal Period in Sows and the Link With Gut Microbiota and Metabolites. Frontiers in Microbiology 9.
Crossref
Crossref
Belal Chami, Nathan J.J. Martin, Joanne M. Dennis & Paul K. Witting. (2018) Myeloperoxidase in the inflamed colon: A novel target for treating inflammatory bowel disease. Archives of Biochemistry and Biophysics 645, pages 61-71.
Crossref
Crossref
Laura Francesca Pisani, Gian Eugenio Tontini, Beatrice Marinoni, Vincenzo Villanacci, Barbara Bruni, Maurizio Vecchi & Luca Pastorelli. (2017) Biomarkers and Microscopic Colitis: An Unmet Need in Clinical Practice. Frontiers in Medicine 4.
Crossref
Crossref
Samantha L Margulies, Divya Kurian, Mark S Elliott & Zhiyong Han. (2015) Vitamin D deficiency in patients with intestinal malabsorption syndromes – think in and outside the gut. Journal of Digestive Diseases 16:11, pages 617-633.
Crossref
Crossref
Aleksandra Tomova, Veronika Husarova, Silvia Lakatosova, Jan Bakos, Barbora Vlkova, Katarina Babinska & Daniela Ostatnikova. (2015) Gastrointestinal microbiota in children with autism in Slovakia. Physiology & Behavior 138, pages 179-187.
Crossref
Crossref
Shan-Ming Chen, Ching-Pin Lin, Jeng-Dau Tsai, Yu-Hua Chao & Ji-Nan Sheu. (2014) The Significance of Serum and Fecal Levels of Interleukin-6 and Interleukin-8 in Hospitalized Children with Acute Rotavirus and Norovirus Gastroenteritis. Pediatrics & Neonatology 55:2, pages 120-126.
Crossref
Crossref
Nathalee Prakash, Phil Stumbles & Caroline Mansfield. (2013) Initial Validation of Cytokine Measurement by ELISA in Canine Feces. Open Journal of Veterinary Medicine 03:06, pages 282-288.
Crossref
Crossref
Omry Koren, Julia K. Goodrich, Tyler C. Cullender, Aymé Spor, Kirsi Laitinen, Helene Kling Bäckhed, Antonio Gonzalez, Jeffrey J. Werner, Largus T. Angenent, Rob Knight, Fredrik Bäckhed, Erika Isolauri, Seppo Salminen & Ruth E. Ley. (2012) Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy. Cell 150:3, pages 470-480.
Crossref
Crossref
Jatinder P. Ahluwalia. (2012) Immunotherapy in Inflammatory Bowel Disease. Medical Clinics of North America 96:3, pages 525-544.
Crossref
Crossref
Bincy P. Abraham & Selvi Thirumurthi. (2009) Clinical significance of inflammatory markers. Current Gastroenterology Reports 11:5, pages 360-367.
Crossref
Crossref
J.L. Mendoza & M.T. Abreu. (2009) Biological markers in inflammatory bowel disease: Practical consideration for clinicians. Gastroentérologie Clinique et Biologique 33, pages S158-S173.
Crossref
Crossref
Dídia Bisamra Cury, Marcelo de Souza Cury, Geraldo Vinicius Hemerly Elias & Sender Jankiel Mizsputen. (2009) Infliximab to treat severe ulcerative colitis. World Journal of Gastroenterology 15:14, pages 1771.
Crossref
Crossref
T. M. McCann, A. E. Ridyard, R. W. Else & J. W. Simpson. (2007) Evaluation of disease activity markers in dogs with idiopathic inflammatory bowel disease. Journal of Small Animal Practice 48:11, pages 620-625.
Crossref
Crossref
D. DESAI, W. A. FAUBION & W. J. SANDBORN. (2007) Review article: biological activity markers in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 25:3, pages 247-255.
Crossref
Crossref
J. P. GISBERT, Y. GONZÁLEZ‐LAMA & J. MATÉ. (2006) Systematic review: infliximab therapy in ulcerative colitis. Alimentary Pharmacology & Therapeutics 25:1, pages 19-37.
Crossref
Crossref
Faten N. Aberra & Gary R. Lichtenstein. (2006) Infliximab in Ulcerative Colitis. Gastroenterology Clinics of North America 35:4, pages 821-836.
Crossref
Crossref
Loren C. Denlinger, Giuditta Angelini, Kathleen Schell, Dawn N. Green, Arturo G. Guadarrama, Usha Prabhu, Douglas B. Coursin, Paul J. Bertics & Kirk Hogan. (2005) Detection of Human P2X7 Nucleotide Receptor Polymorphisms by a Novel Monocyte Pore Assay Predictive of Alterations in Lipopolysaccharide-Induced Cytokine Production. The Journal of Immunology 174:7, pages 4424-4431.
Crossref
Crossref
Fabio Cominelli, Kristen O. Arseneau & Theresa T. Pizarro. 2005. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
147
176
.
Stephen B. Hanauer & Miles Sparrow. (2004) Therapy of ulcerative colitis. Current Opinion in Gastroenterology 20:4, pages 345-350.
Crossref
Crossref
Martin Philpott & Lynnette R Ferguson. (2004) Immunonutrition and cancer. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 551:1-2, pages 29-42.
Crossref
Crossref
Stephen B Hanauer. (2004) Medical therapy for ulcerative colitis 2004. Gastroenterology 126:6, pages 1582-1592.
Crossref
Crossref
Andrzej Wedrychowicz, Janina Stopyrowa, Krzysztof Fyderek & Witold Miezynski. (2003) Stool interleukin 1β and interleukin 1 receptor antagonist concentrations in children with active ulcerative colitis and during recovery. European Journal of Pediatrics 162:7-8, pages 541-542.
Crossref
Crossref
T SCHEININ, D M BUTLER, F SALWAY, B SCALLON & M FELDMANN. (2003) Validation of the interleukin-10 knockout mouse model of colitis: antitumour necrosis factor-antibodies suppress the progression of colitis. Clinical and Experimental Immunology 133:1, pages 38-43.
Crossref
Crossref
Fabio Cominelli, Kristen O. Arseneau & Theresa T. Pizarro. 2003. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
147
176
.
J Lindsay, C van Montfrans, F Brennan, S van Deventer, P Drillenburg, H Hodgson, A te Velde & M Sol Rodriguez Pena. (2002) IL-10 gene therapy prevents TNBS-induced colitis. Gene Therapy 9:24, pages 1715-1721.
Crossref
Crossref
Chinyu Su, Bruce A. Salzberg, James D. Lewis, Julius J. Deren, Asher Kornbluth, David A. Katzka, Robert B. Stein, Douglas R. Adler & Gary R. Lichtenstein. (2002) Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis. The American Journal of Gastroenterology 97:10, pages 2577-2584.
Crossref
Crossref
A. Poullis, R. Foster, T. C. Northfield & M. A. Mendall. (2002) Faecal markers in the assessment of activity in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 16:4, pages 675-681.
Crossref
Crossref
Susan K. Bunn, W. Michael Bisset, Margaret J. C. Main, Elizabeth S. Gray, Shona Olson & Barbara E. Golden. (2001) Fecal Calprotectin: Validation as a Noninvasive Measure of Bowel Inflammation in Childhood Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 33:1, pages 14-22.
Crossref
Crossref
Susan K. Bunn, W. Michael Bisset, Margaret J. C. Main, Elizabeth S. Gray, Shona Olson & Barbara E. Golden. (2001) Fecal Calprotectin: Validation as a Noninvasive Measure of Bowel Inflammation in Childhood Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 33:1, pages 14-22.
Crossref
Crossref
Gary R. Lichtenstein. (2001) Is Infliximab Effective for Induction of Remission in Patients with Ulcerative Colitis?. Inflammatory Bowel Diseases 7:2, pages 89-93.
Crossref
Crossref
Suman Kumari, Kailash C. Bhol, Farah Rehman, C.Stephen Foster & A.Razzaque Ahmed. (2001) INTERLEUKIN 1 COMPONENTS IN CICATRICIAL PEMPHIGOID. ROLE IN INTRAVENOUS IMMUNOGLOBULIN THERAPY. Cytokine 14:4, pages 218-224.
Crossref
Crossref
Susan K. Bunn, W. Michael Bisset, Margaret J.C. Main & Barbara E. Golden. (2001) Fecal Calprotectin as a Measure of Disease Activity in Childhood Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 32:2, pages 171-177.
Crossref
Crossref
Susan K. BunnW. Michael BissetMargaret J.C. MainBarbara E. Golden. (2001) Fecal Calprotectin as a Measure of Disease Activity in Childhood Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 32:2, pages 171-177.
Crossref
Crossref
Keiichi Mitsuyama, Asuka Suzuki, Nobuo Tomiyasu, Kosuke Takaki, Atsushi Toyonaga & Michio Sata. (2001) Transcription Factor-Targeted Therapies in Inflammatory Bowel Disease. Digestion 63:Suppl. 1, pages 68-72.
Crossref
Crossref
M. Göke. 2001. Chronisch entzündliche Darmerkrankungen. Chronisch entzündliche Darmerkrankungen
93
102
.
Marla C. Dubinsky & Ernest G. Seidman. (2000) Diagnostic markers of inflammatory bowel disease. Current Opinion in Gastroenterology 16:4, pages 337-342.
Crossref
Crossref
NMA Blijlevens, JP Donnelly & BE De Pauw. (2000) Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplantation 25:12, pages 1269-1278.
Crossref
Crossref
Ole H Nielsen, Ben Vainer, Søren M Madsen, Jacob B Seidelin & Niels H H Heegaard. (2000) Clinical Reviews. American Journal of Gastroenterology 95:2, pages 359-367.
Crossref
Crossref
I. Lilja, C. Gustafson-Svärd, L. Franzén & R. Sjödahl. (2000) Tumor Necrosis Factor-Alpha in Ileal Mast Cells in Patients with Crohn’s Disease. Digestion 61:1, pages 68-76.
Crossref
Crossref